Yes — Crispr Therapeutics has a documented H-1B filing history: official US Department of Labor disclosure data lists 12 H-1B labor condition application (LCA) records for this employer. The most recent imported disclosure period is FY2026 Q2.
An LCA is the labor-condition step an employer must file with DOL before USCIS can approve an H-1B petition, so these rows are documented sponsorship activity — not a promise that Crispr Therapeutics will sponsor a new hire, and not evidence that any petition was approved. USCIS decides each petition separately. Verified against official DOL OFLC disclosure data on 2026-08-09.
Green-card signal
Does Crispr Therapeutics file PERM green-card cases?
Not in this dataset — official DOL disclosure data lists no PERM (green-card) records for Crispr Therapeutics, though it does list 12 H-1B labor condition application (LCA) records. The most recent imported disclosure period is FY2026 Q2.
H-1B filing activity without PERM rows is common and is not evidence that Crispr Therapeutics refuses to sponsor green cards: PERM cases are published on their own disclosure calendar, are often filed years after the first H-1B, and appear under whichever legal entity files them. Treat missing PERM rows as an absence of evidence for the imported source periods, not as evidence of absence. Verified against official DOL OFLC PERM disclosure data on 2026-08-09.
Summary
Plain-language read
Crispr Therapeutics has filed 12 Labor Condition Applications (LCA) in FY2026 Q2, with all applications certified. The top roles include Principal Research Associate and Manager, Regulatory Affairs, primarily located in Boston, MA. Salary data indicates a median of $123,838, with a range from $102,000 to $320,000. Notably, there are no PERM applications filed, which may impact long-term employment options. It's important to remember that LCA certification does not guarantee USCIS H-1B petition approval, and PERM certification does not equate to green card approval. This information is not legal advice.
Wondering whether Crispr Therapeutics sponsors H-1B? The H-1B sponsor checker reads any company against the same official LCA and PERM filing signals shown here.
Crispr Therapeutics H-1B and PERM research checkpoints
Use this section for searches such as "Crispr Therapeutics H-1B", "Crispr Therapeutics LCA", and "Crispr Therapeutics PERM" before comparing individual case rows.
Activity mix
12 LCA rows and 0 PERM rows are normalized to this employer.
Name matching is a normalization heuristic. Read the source methodology and import freshness before treating matched aliases as a complete sponsor history.
Filing trends
Crispr Therapeutics H-1B/LCA & PERM filing charts
Server-rendered charts from imported DOL OFLC disclosure data. Filing counts are official signals — not sponsorship, hiring, or approval outcomes.
Imported filings by fiscal year
Crispr Therapeutics shows 12 imported H-1B/LCA and PERM filings in FY2026. Counts are imported DOL filing signals, not sponsorship, hiring, or approval outcomes.
H-1B/LCAPERM
Crispr Therapeutics imported H-1B/LCA and PERM filing counts by fiscal year
Fiscal year
H-1B/LCA filings
PERM filings
Total filings
FY2026
12
0
12
Wage distribution (recent imported records)
Crispr Therapeutics imported wage records (n=10) span $102,000 to $320,000, with a middle 50% from $120,000 to $177,480 and a median of $123,838.
Median $123,838
Crispr Therapeutics imported annual wage distribution (US dollars) across recent LCA and PERM records
Minimum
$102,000
25th percentile
$120,000
Median
$123,838
75th percentile
$177,480
Maximum
$320,000
Records
10
Source: DOL OFLC disclosure data, retrieved .
Roles
Top official job titles
Principal Research Associate4
Manager, Regulatory Affairs2
Senior Medical Director, Pharmacovigilance2
Senior Research Associate, Translational Biology2
Associate Clinical Trial Manager1
Worksites
Top locations
Boston, MA12
Status mix
Case statuses
Certified12
Related sponsors
Sponsors adjacent to Crispr Therapeutics
Employers with imported DOL LCA or PERM filings that also list Massachusetts worksites, weighted toward overlapping roles. Shared filing footprints are a research and discovery signal, not a hiring or sponsorship guarantee.
LCA and PERM rows are filing signals, not USCIS approvals, green-card approvals, legal advice, or outcome predictions.
FAQ
Common questions
Does Crispr Therapeutics sponsor H-1B workers?
Yes — Crispr Therapeutics has a documented H-1B filing history: official US Department of Labor disclosure data lists 12 H-1B labor condition application (LCA) records for this employer. The most recent imported disclosure period is FY2026 Q2. An LCA is the labor-condition step an employer must file with DOL before USCIS can approve an H-1B petition, so these rows are documented sponsorship activity — not a promise that Crispr Therapeutics will sponsor a new hire, and not evidence that any petition was approved. USCIS decides each petition separately. Verified against official DOL OFLC disclosure data on 2026-08-09.
Does Crispr Therapeutics file PERM green-card cases?
Not in this dataset — official DOL disclosure data lists no PERM (green-card) records for Crispr Therapeutics, though it does list 12 H-1B labor condition application (LCA) records. The most recent imported disclosure period is FY2026 Q2. H-1B filing activity without PERM rows is common and is not evidence that Crispr Therapeutics refuses to sponsor green cards: PERM cases are published on their own disclosure calendar, are often filed years after the first H-1B, and appear under whichever legal entity files them. Treat missing PERM rows as an absence of evidence for the imported source periods, not as evidence of absence. Verified against official DOL OFLC PERM disclosure data on 2026-08-09.
What does VisaSignal show for Crispr Therapeutics H-1B and PERM?
For Crispr Therapeutics H-1B research, the page summarizes imported DOL LCA labor-condition rows. For Crispr Therapeutics PERM research, it summarizes imported DOL permanent labor certification rows. Both include roles, worksites, wage signals, case-status mix, and the latest source period.
Does an LCA certification mean an H-1B petition was approved?
No. A DOL-certified LCA is not the same as USCIS H-1B petition approval. It is an official labor-condition filing signal that should be interpreted with that limit.
Does a PERM certification mean a green card was approved?
No. PERM certification is one step in an employment-based green card process. It does not mean a green card, I-140 petition, or adjustment of status was approved.
Can this data prove an employer will sponsor a candidate?
No. Official filing history can show recent activity, roles, worksites, and wage signals, but it does not guarantee future sponsorship or predict legal outcomes.